Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed1
Other3

Role Distribution

Principal Investigator1
Other Roles3
PI Rate25%

Activity Timeline

Clinical Trials (4)

NCT06263010Phase 1Completed
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease
Parkinson Disease
StudydirectorStart date: 2024-01-12
NCT05664477Phase 2Active Not Recruiting
PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
Brain Disorder, MetabolicCognitive ChangeMenopause
PrincipalinvestigatorStart date: 2024-01-10
NCT06186531Phase 2Unknown
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
Hot FlashesMenopause
StudydirectorStart date: 2023-11-17
NCT04838301Phase 2Active Not Recruiting
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Alzheimer DementiaLate Onset Alzheimer DiseaseNeurodegenerative Diseases
StudydirectorStart date: 2023-08-15

Research Network

Collaboration Network

7 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Roberta D Brinton, PhD

University of Arizona

Very Similar
4 trials

Shared therapeutic areas:

Alzheimer DiseaseBrain Diseases, MetabolicCognitive Change+4 more

Worked with same sponsors:

ADM DiagnosticsCornell University+5 more
Collaborated on 3 trials
Similarity Score82%

Lon Schneider, MD

University of Southern California

Moderately Similar
2 trials

Shared therapeutic areas:

Alzheimer DiseaseAlzheimer Disease, Late OnsetNeurodegenerative Diseases

Worked with same sponsors:

ADM DiagnosticsNational Institute on Aging (NIA)+3 more
Collaborated on 1 trial
Similarity Score34%

Fei Yin, PhD

University of Arizona

Related
1 trials

Shared therapeutic areas:

Hot FlashesMenopause

Worked with same sponsors:

NeuTherapeuticsUniversity of Arizona
Collaborated on 1 trial
Similarity Score24%

Scott Sherman, MD

University of Arizona

Related
1 trials

Shared therapeutic areas:

Parkinson Disease

Worked with same sponsors:

Roberta Brinton
Collaborated on 1 trial
Similarity Score14%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Alzheimer DiseaseParkinson DiseaseAlzheimer Disease, Late Onset
Similarity Score11%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

Alzheimer DiseaseParkinson Disease
Similarity Score8%

Nieto Luis

Site Coordinator of United Medical Group

Related
23 trials

Shared therapeutic areas:

Alzheimer DiseaseParkinson Disease
Similarity Score8%

Nieto Luis, Master

Site Coordinator of United Medical Group

Related
38 trials

Shared therapeutic areas:

Parkinson DiseaseAlzheimer Disease
Similarity Score8%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Alzheimer DiseaseParkinson Disease
Similarity Score8%

Danna Jennings, MD

Institute for Neurodegenerative Disorders

Related
18 trials

Shared therapeutic areas:

Alzheimer DiseaseParkinson Disease
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06263010Phase 1StudyDirector

Allopregnanolone as a Regenerative Treatment for Parkinson's Disease

Parkinson Disease
Completed
NCT05664477Phase 2PrincipalInvestigator

PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

Brain Disorder, MetabolicCognitive ChangeMenopause
Active Not Recruiting
NCT06186531Phase 2StudyDirector

PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health

Hot FlashesMenopause
Unknown
NCT04838301Phase 2StudyDirector

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Alzheimer DementiaLate Onset Alzheimer DiseaseNeurodegenerative Diseases
Active Not Recruiting

All 4 trials loaded